Why Is PACS GROUP INC EQUIT Equity (PACS) Stock Down Today?

PACS Group Inc. stock fell 7.22% to $44.95 on Tuesday, marking a sharp decline despite recent analyst upgrades and strong quarterly revenue. The move followed the company’s Q2 2026 earnings call, where it reported a net income increase of 49.8% but missed earnings estimates. The stock’s performance was also influenced by a series of recent insider sales totaling $34.0 million in the last 90 days.

What Happened

The earnings call highlighted a surge in net income and a 150 basis point expansion in adjusted EBITDA margin, yet the stock reacted negatively. Earnings per share came in at $0.47, below the $0.53 estimate. While revenue of $1.427 billion beat the $1.415 billion forecast, the earnings miss and mixed operational results likely contributed to the sell-off. In the broader context, several major banks including Oppenheimer, UBS, RBC Capital, and Truist Securities have maintained positive ratings on PACS, with price targets ranging from $57 to $62. However, the recent insider sales, particularly by executives and directors, may have signaled caution among investors.

What The Data Shows

PACS has a market cap of $7.4 billion and a P/E ratio of 28.2, with trailing twelve-month revenue growth of 15.2%. The stock’s 52-week range is $7.50 to $49.49, and it currently trades near the upper end of that range. The recent insider sales, including transactions by President and COO Joshua Jergensen and Director Mark Hancock, have raised questions about internal confidence. The stock has seen a 30-day average sentiment score of 56 out of 100, improving to 61 in the last seven days, suggesting some positive momentum despite the recent drop.

What To Watch

PACS is scheduled to report Q2 2026 earnings in the coming weeks. Investors will be watching for further clarity on the company’s earnings trajectory and how management addresses the recent insider sales.